Skip to main content
Clinical Trials/IRCT2017101436753N1
IRCT2017101436753N1
Recruiting
Phase 3

Evaluation of the effect of furosemide inhalation versus placebo in patients with acute cardiogenic pulmonary edema

Vice chancellor for research, Iran University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Acute pulmonary oedema.
Sponsor
Vice chancellor for research, Iran University of Medical Sciences
Enrollment
120
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Iran University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • All the patients with acute cardiogenic edema will be included in the study.
  • Exclusion criteria: not willing to participate in the study, history of susceptibility to sulfa drugs, unstable hemodynamics; requiring mechanical ventilation; decreased consciousness, accompany with another illness requiring treatment in the first 10 minutes of treatment with digoxin, beta blocker, beta\-agonist and calcium; need to have another inhaling treatment in the first 10 minutes and need to have non\-invasive ventilation.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials